Cystic fibrosis and normal human airway epithelial cell response to influenza A viral infection

Journal of Interferon and Cytokine Research

Volumn 26, Issue 9, 2006, Pages 609-627

  Xu, Weiling ^a   Zheng, Shuo ^a   Goggans, Tannishia M ^a   Kiser, Patti ^a   Quinones Mateu, Miguel E ^a   Janocha, Allison J ^a   Comhair, Suzy A A ^a   Slee, Roger ^a   Williams, Bryan R G ^a   Erzurum, Serpil C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT1 PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INFLUENZA VIRUS A; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; UNINDEXED SEQUENCE; VIRAL RESPIRATORY TRACT INFECTION;

CELLS, CULTURED; CHILD; CYSTIC FIBROSIS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RESPIRATORY MUCOSA;

EID: 33750625572     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.609     Document Type: Article

References (69)

1. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T, Arstila P. Viruses and bacteria in the etiology of the common cold. J. Clin. Microbiol. 1998;36:539-542.
2. Jacoby DB. Virus-induced asthma attacks. JAMA 2002;287:755-761.
3. File TM. Viral respiratory tract infections: increasing importance and a new pathogen. Curr. Opin. Infect. Dis. 2003;16:125-127.
4. Wat D, Doull I. Respiratory virus infections in cystic fibrosis. Paediatr. Respir. Rev. 2003;4:172-177.
5. Uetani K, Der SD, Zamanian-Daryoush M, de La Motte C, Lieberman BY, Williams BR, Erzurum SC. Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J. Immunol. 2000;165:988-996.
6. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism. J. Virol. 1998;72:8550-8558.
7. Kao YJ, Piedra PA, Larsen GL, Colasurdo GN. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 2001;163:532-539.
8. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 1998;157:1708-1720.
9. Mossman KL. Activation and inhibition of virus and interferon: the herpesvirus story. Viral Immunol. 2002;15:3-15.
10. Guerra S, Lopez-Fernandez LA, Conde R, Pascual-Montano A, Harshman K, Esteban M. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J. Virol. 2004;78:5820-5834.
11. Haig DM. Subversion and piracy: DNA viruses and immune evasion. Res. Vet. Sci. 2001;70:205-219.
12. Tong HH, Long JP, Li D, DeMaria TF. Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb. Pathog. 2004;37:193-204.
13. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J. Virol. 2001;75:4321-4331.
14. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J. Allergy Clin. Immunol. 1996;98:1080-1087.
15. Zhu Z, Tang W, Ray A, Wu Y, Einarsson O, Landry ML, Gwaltney J Jr., Elias JA. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Invest. 1996;97:421-430.
16. Zheng S, De BP, Choudhary S, Comhair SA, Goggans T, Slee R, Williams BR, Pilewski J, Haque SJ, Erzurum SC. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 2003;18:619-630.
17. Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, Phelan PD. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr. Pulmonol. 1998;26:371-379.
18. Hordvik NL, Konig P, Hamory B, Cooperstock M, Kreutz C, Gayer D, Barbero G. Effects of acute viral respiratory tract infections in patients with cystic fibrosis. Pediatr. Pulmonol. 1989;7:217-222.
19. Hiatt PW, Grace SC, Kozinetz CA, Raboudi SH, Treece DG, Taber LH, Piedra PA. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999;103:619-626.
20. Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med. 1984;311:1653-1658.
21. Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma-possible synergism with Pseudomonas aeruginosa. Acta Paediatr. Scand. 1981;70:623-628.
22. Ferson MJ, Morton JR, Robertson PW. Impact of influenza on morbidity in children with cystic fibrosis. J. Paediatr. Child. Health 1991;27:308-311.
23. Malfroot A, Adam G, Ciofu O, Doring G, Knoop C, Lang AB, Van Damme P, Dab I, Bush A. Immunization in the current management of cystic fibrosis patients. J. Cyst. Fibrosis 2005;4:77-87.
24. Zheng S, Xu W, Bose S, Banerjee AK, Haque SJ, Erzurum SC. Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell Mol. Physiol. 2004;287:L374-381.
25. Guo FH, Uetani K, Haque SJ, Williams BR, Dweik RA, Thunnissen FB, Calhoun W, Erzurum SC. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 1997;100:829-838.
26. Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR. p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 2003;23:425-436.
27. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001;69:912-920.
28. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, Sen GC. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 2001;276:30178-30182.
29. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat. Genet. 1999;21:20-24.
30. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, Bond M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000;102:3046-3052.
31. Wang J, Gao P. In vitro expression of Penicillium janthinellum cellobiohydrolase I gene in a coupled transcription-translation system. J. Biotechnol. 2000;81:205-209.
32. Harder J, Battels J, Christophers E, Schroder JM. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001;276:5707-5713.
33. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 2000;68:2907-2915.
34. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel h, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003;17:F39-48.
35. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet. Microbiol. 2000;74:109-116.
36. Kramps JA, Franken C, Meijer CJ, Dijkman JH. Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract. J. Histochem. Cytochem. 1981;29:712-719.
37. Sallenave JM, Si Tahar M, Cox G, Chignard M, Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukoc. Biol. 1997;61:695-702.
38. Masuda K, Suga T, Takeuchi A, Kanesaki M, Imaizumi A, Suzuki Y. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva. Biochem. Pharmacol. 1994;48:651-657.
39. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 1995;96:456-464.
40. McNeely TB, Shugars DC, Rosendahl M, Tucker C, Eisenberg SP, Wahl SM. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997;90:1141-1149.
41. Baqui AA, Meiller TF, Falkler WA Jr. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients. Clin. Diagn. Lab. Immunol. 1999;6:808-811.
42. Lin AL, Johnson DA, Stephan KT, Yeh CK. Salivary secretory leukocyte protease inhibitor increases in HIV infection. J. Oral Pathol. Med. 2004;33:410-416.
43. McCray PB Jr, Bentley L. Human airway epithelia express a beta-defensin. Am. J. Respir. Cell Mol. Biol. 1997;16:343-349.
44. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB Jr. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 1998;95:14961-14966.
45. Harder J, Meyer-Hoffert U, Ter an LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am. J. Respir. Cell. Mol. Biol. 2000;22:714-721.
46. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
47. Gropp R, Frye M, Wagner TO, Bargon J. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum. Gene Ther. 1999;10:957-964.
48. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528.
49. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 1986;60:1068-1074.
50. Duits LA, Nibbering PH, van Strijen E, Vos JB, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. Rhinovirus increases human beta-defensin-2 and -3 mRNA expression in cultured bronchial epithelial cells. FEMS Immunol. Med. Microbiol. 2003;38:59-64.
51. Gao J, De BP, Banerjee AK. Human parainfluenza virus type 3 upregulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a Stat1- and CI-ITA-independent pathway. J. Virol. 1999;73:1411-1418.
52. Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D, Yagi S, Dolganov G, Boushey H, Avila P, Wu R. Rhinovirus induces airway epithelial gene expression through dsRNA and interferon-dependent pathways. Am. J. Respir. Cell Mol. Biol. 2005;34:192-203.
53. Khabar KS, Al-Haj L, Al-Zoghaibi F, Marie M, Dhalla M, Polyak SJ, Williams BR. Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon. J. Mol. Biol. 2004;342:833-846.
54. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P, Julkunen I. Regulation of IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J. Immunol. 1997;158:2363-2374.
55. Behera AK, Kumar M, Lockey RF, Mohapatra SS. 2′-5′ Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J. Biol. Chem. 2002;277:25601-25608.
56. Clemens MJ, Williams BR. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 1978;13:565-572.
57. Saunders ME, Gewert DR, Tugwell ME, McMahon M, Williams BR. Human 2-5 A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J. 1985;4:1761-1768.
58. Benech P, Mory Y, Revel M, Chebath J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J. 1985;4:2249-2256.
59. Samuel CE. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
60. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 2001;98:15125-15130.
61. Nichols IE, Niles JA, Roberts NJ Jr. Human lymphocyte apoptosis after exposure to influenza A virus. J. Virol. 2001;75:5921-5929.
62. Takizawa T, Matsukawa S. Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 1993;74:2347-2355.
63. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 2003;34:1507-1516.
64. Cannon CL, Kowalski MP, Stopak KS, Pier GB. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell. Mol. Biol 2003;29:188-197.
65. Cobb LM, Mychaleckyj JC, Wozniak DJ, Lopez-Boado YS. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J. Immunol. 2004;173:5659-5670.
66. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-560.
67. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 2003;284:L566-577.
68. Lukacs NW, Hogaboam C, Campbell E, Kunkel SL. Chemokines: function, regulation and alteration of inflammatory responses. Chem. Immunol. 1999;72:102-120.
69. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997;15:675-705.